Skip to main content
AMINOLOGICS CO.,LTD. logo

AMINOLOGICS CO.,LTD. — Investor Relations & Filings

Ticker · 074430 ISIN · KR7074430000 KO Manufacturing
Open in API
Filings indexed 115 across all filing types
Latest filing 2024-03-20 Audit Report / Informat…
Country KR South Korea
Listing KO 074430

About AMINOLOGICS CO.,LTD.

https://aminologics.co.kr/eng/main/

AMINOLOGICS CO.,LTD. is a specialty manufacturer of amino acids and their derivatives. The company's core competency is its proprietary chiral resolution platform technology, ARCA (Alanine Racemase Chiral). This innovative enzymatic process enables the cost-effective production of a wide range of high-purity chiral amino acids. These products serve as essential building blocks and Active Pharmaceutical Ingredients (APIs) for various sectors, including the pharmaceutical, fine chemical, agrochemical, and life science industries. The technology allows for the development of new products and treatments by providing materials with high optical purity at a reduced cost.

Recent filings

Filing Released Lang Actions
사업보고서 (2023.12)
Audit Report / Information Classification · 95% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the fiscal year 2023, including the independent auditor's opinion, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. While it contains financial data, it is the formal audit report issued by an external accounting firm (Seowoo Accounting Corp) rather than the company's own management-prepared Annual Report (10-K). In the context of the provided categories, this fits the 'Audit Report / Information' (AR) classification. FY 2023
2024-03-20 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for Aminologics Co., Ltd. It contains the meeting agenda, voting procedures, proxy information, and management reports (such as audit reports and board activities) required for the upcoming AGM. This fits the definition of materials shared for an Annual General Meeting.
2024-03-13 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard Korean regulatory filing (Proxy Solicitation) used to request shareholder votes for an upcoming Annual General Meeting (AGM). It includes details about the meeting, the agenda (approval of financial statements), and instructions for electronic voting. While it contains financial data, it is a proxy statement, not the annual report itself.
2024-03-07 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains information about the meeting agenda, proxy solicitation details, and financial statements. This document type is specifically designed to provide shareholders with the necessary information to vote, fitting the definition of a Proxy Solicitation & Information Statement.
2024-03-05 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Aminologics. It outlines the date, location, and agenda items (such as financial statement approval and director compensation) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of the meeting and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2024-02-29 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (AminoLogics) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean market (DART system) for material financial changes. Since it provides the initial financial highlights and key figures before the final audited annual report is finalized, it fits the definition of an Earnings Release (ER). FY 2023
2024-02-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.